findmyKOL
Clinical trialNCT01042288CompletedPhase 2Interventional

Carboplatin, Pemetrexed, and Panitumumab in Patients With Advanced Non-Squamous K-ras Wild Type NSCLC

SponsorSCRI Development Innovations, LLCEnrollment70Non-Small-Cell Lung Cancer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Florida Cancer Specialists

    Fort Myers, Florida, United States

  • Florida Hospital Cancer Institute

    Orlando, Florida, United States

  • Medical Oncology Associates of Augusta

    Augusta, Georgia, United States

  • Northeast Georgia Medical Center

    Gainesville, Georgia, United States

  • Baptist Hospital East

    Louisville, Kentucky, United States

  • Norton Cancer Institute

    Louisville, Kentucky, United States

  • Center for Cancer and Blood Disorders

    Bethesda, Maryland, United States

  • National Capital Clinical Research Consortium

    Bethesda, Maryland, United States

  • Portsmouth Regional Hospital

    Portsmouth, New Hampshire, United States

  • Oncology Hematology Care

    Cincinnati, Ohio, United States

  • Cancer Centers of Southwest Oklahoma

    Lawton, Oklahoma, United States

  • Tennessee Oncology, Pllc

    Nashville, Tennessee, United States

  • Peninsula Cancer Institute

    Newport News, Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Jun 2010
Primary completion
31 Dec 2014
Completion
31 Jul 2015
Last update posted
11 May 2016
Registered enrollment
70
Registry id
NCT01042288

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.